Sanofi's reversible BTK inhibitor rilzabrutinib has gained the US Food and Drug Administration’s (FDA) orphan drug ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Boehringer Ingelheim subsidiary NBE Therapeutics has opened its new antibody-drug conjugates (ADC) R&D facility in Basel, ...

Streeting said his June 10-year plan will address drug sale clawbacks, NICE regulation, and the abolition of NHS England.

Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Astellas Pharma has entered a strategic partnership with the JFCR to expedite research in translational and clinical oncology ...

Late-stage pipeline products anticipated to reach the uveitis market during the forecast period will introduce new mechanisms ...

The formulation allows for greater stockpiling, with Bavarian Nordic already working with the US government to add to vaccine ...

The EC has approved Daiichi Sankyo and AstraZeneca’s Enhertu for use as a single agent to treat adults with certain breast ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

The establishment of NHS England (NHSE) to undertake functions previously the responsibility of the then Department of Health ...